Method for increasing non-homologous end joining efficiency of CRIPSR/Cas9 target knock-out genes
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 重庆高圣生物医药有限责任公司
- Publication Date
- 2017-06-30
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical fields of molecular biology and biomedicine, and in particular relates to a method for improving the efficiency of non-homologous end joining (NHEJ) of CRIPSR / Cas9 targeted knockout genes. Background technique
[0002] The CRISPR / Cas system is developed from the adaptive immune system of bacteria and archaea against foreign viruses or plasmids, including three different types, of which the DNA endonuclease Cas9 of the Type Ⅱ CRISPR / Cas system has only one subclass. The base has the simplest structure, so it is the most widely used. In addition to the Cas9 protein, the system also includes two short CRISPR RNAs (crRNAs) and trans-activating crRNAs (tracrRNA). The mature crRNA-tracrRNA complex can guide the Cas9 protein to the target sequence through complementary base pairing, and specifically cut the DNA double strand near the PAM (protospace radjacent motif) to form a DSB (double strand break). DSB can be repai...